Lexston Life Sciences Corp. (TSE:LEXT)
CNQX:LEXT
Canadian Market

Lexston Life Sciences Corp. (LEXT) Financial Statements

3 Followers

Lexston Life Sciences Corp. Financial Overview

Lexston Life Sciences Corp.'s market cap is currently ―. The company's EPS TTM is C$-0.022; its P/E ratio is -2.86; Lexston Life Sciences Corp. is scheduled to report earnings on September 23, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 23Aug 23May 23Feb 23Nov 22
Income Statement-
Total Revenue----C$ 0.00
Gross Profit----C$ 0.00
EBITC$ -138.18KC$ -112.42KC$ -84.12KC$ -304.98KC$ -409.50K
EBITDAC$ -131.60KC$ -105.80KC$ -77.16KC$ -298.35KC$ -401.90K
Net Income Common StockholdersC$ -138.18KC$ -112.42KC$ -84.12KC$ -304.98KC$ -430.43K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 233.87KC$ 569.45KC$ 511.00KC$ 686.88KC$ 994.10K
Total AssetsC$ 576.16KC$ 712.28KC$ 814.30KC$ 896.13KC$ 1.20M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -233.87KC$ -569.45KC$ -511.00KC$ -686.88KC$ -994.10K
Total LiabilitiesC$ 22.16KC$ 21.61KC$ 11.21KC$ 8.92KC$ 8.60K
Stockholders EquityC$ 554.00KC$ 690.68KC$ 803.10KC$ 887.22KC$ 1.19M
Cash Flow-
Free Cash FlowC$ -337.08KC$ 58.46KC$ -175.88KC$ -307.22KC$ -335.72K
Operating Cash FlowC$ -337.08KC$ 58.46KC$ -175.88KC$ -307.22KC$ -335.72K
Investing Cash Flow----C$ 0.00
Financing Cash FlowC$ 1.50K---C$ 0.00
Currency in CAD

Lexston Life Sciences Corp. Earnings and Revenue History

Lexston Life Sciences Corp. Debt to Assets

Lexston Life Sciences Corp. Cash Flow

Lexston Life Sciences Corp. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis